The most expensive pharmaceuticals include Zolgensma, Zokinvy, Danyelza, Luxturna, Ravicti, Myalept, and more.

The Indiana-based drugmaker is slashing the prices of its 2.5 mg single-dose vials to $349 per month and bringing its 5 mg single-dose vials down to $499 per month, it said in a Tuesday press release.

Amryt’s commercial business comprises two orphan disease products – metreleptin (Myalept®/ Myalepta®) and lomitapide (Juxtapid®/ Lojuxta®). Myalept® / Myalepta® (metreleptin) is approved ...

Police allegedly found the vial after Mr Nadir and Sarah Abu Lebdeh were stood down from their roles at Bankstown Hospital following the emergence of the video, 7NEWS reported. After Mr Nadir ...

Clinical study I: Body Weight, Metabolic, and Immune Responses to Metreleptin Versus Placebo Treatment in Obese Hyperleptinemic Subjects with Diabetes No Differential Activation of MAPK Signaling ...

Metreleptin, mibavademab, and others. • In February 2025, COUR Pharmaceuticals announced that the FDA cleared its Investigational New Drug (IND) application for CNP-103, a nanoparticle therapy ...